NCT00378534
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +25 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,094 public trials
2,044 recruiting studies
Lymphoproliferative Disorders trial results
NCT03692988
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dementia, +16 more
- Locations
-
- University of Zurixh Zurich, Switzerland
NCT02569320
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT01768845
- Conditions
- Acute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Anemia, +42 more
- Locations
-
- West Virginia University Hospitals Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States
NCT00103285
- Conditions
- Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia, Hematologic Diseases, +10 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Banner Children's at Desert Mesa, Arizona, United States
NCT01132807
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
- Locations
-
- Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- CCOP - Christiana Care Health Services Newark, Delaware, United States
Completed
Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies
NCT00988013
- Conditions
- Acute Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +24 more
- Locations
-
- University of Illinois at Chicago Chicago, Illinois, United States
Completed
UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment
NCT02499081
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- University of Arkansas for Medical Science Little Rock, Arkansas, United States
NCT01188681
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
- Locations
-
- For additional information regarding sites for this trial call (919) 465-4648 Denver, Colorado, United States
- For additional information regarding sites for this trial call (919) 465-4648 Augusta, Georgia, United States
- For additional information regarding sites for this trial call (919) 465-4648 Chicago, Illinois, United States
- For additional information regarding sites for this trial call (919) 465-4648 Hackensack, New Jersey, United States
NCT02093663
- Conditions
- Colitis, Colitis, Ulcerative, Colonic Diseases, +16 more
- Locations
-
- University of Maryland Children's Hospital Baltimore, Maryland, United States
- John Hopkins Baltimore, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Newton Wellesley Hospital Newton, Massachusetts, United States